NSG prolactin humanized mouse model to evaluate therapeutic strategies of ER+ breast cancer

Summary of the technology

Researchers at Georgetown University and the University of Nebraska have developed a humanized mouse model expressing the human prolactin gene, to better study ER+ breast cancer. Current models do not properly represent the hormonal environment seen in patients. Furthermore, mouse prolactin fails to activate human prolactin receptors in xenograft experiments, ultimately selecting for prolactin-independent tumor growth and differentiation.

This model overcomes these limitations by replacing the mouse prolactin gene, with a knock-in of human prolactin, therefore mimicking the hormonal environment of breast cancer patients. Crossing these mice with immunodeficient strains, allows for human cell transplantation and engraftments to reliably study ER+ breast cancer.

BACKGROUND

High levels of circulating prolactin have been associated with an increased risk of breast cancer. Together with ER and PR, prolactin plays a crucial role in breast development, influencing both mammary cell proliferation and differentiation. Although prolactin receptors are expressed in the majority of breast cancers, current mouse models fail to account for the hormonal environment seen in patients. In these models, human prolactin is not sufficient to activate mouse prolactin receptors, while mouse prolactin acts as an antagonist to the human prolactin receptor. The NSG-Pro mouse overcomes these issues by expressing the human prolactin gene allowing for physiological levels of circulating human prolactin, and therefore more reliable assessments of disease progression and drug response.

Georgetown University

Benefit

  • NSG-Pro animals express physiological levels of circulating human prolactin
  • Mice better recapitulate the hormonal environment seen in breast cancer patients, allowing for tumors to grow and respond to drugs similarly to that seen in patients
  • Provides a reliable and accurate model to study breast cancer progression, as well as drug responsiveness

Market Application

  • Pharmaceutical companies and academic groups can use this mouse model in preclinical settings to evaluate drug development and to more accurately study disease progression.
  • This mouse model has been non-exclusively licensed to Jackson Laboratory so that researchers can order the mouse model through Jackson Labs. The mice can be found specifically under this link: https://www.jax.org/strain/036917

Publications

  • NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. Sci Adv. 2021 Sep 17;7(38):eabc8145. doi: 10.1126/sciadv.abc8145. Epub 2021 Sep 15. PMID: 34524841; PMCID: PMC8443188.

Other

OTC Contact: Tracy L. Bruehs, J.D., M.S., Director – tlb23@georgetown.edu for more information or assistance with ordering through Jackson Labs (https://www.jax.org/strain/036917)

Related Keywords

  • Cytology, Cancerology, Oncology
  • Medical Research
  • Medical Technology / Biomedical Engineering
  • Medical/health
  • prolactin gene

About Georgetown University

Our mission is to advance GU’s innovations through strategic alliances and new venture creation, to facilitate the translation of research breakthroughs into tangible solutions, and to cultivate a dynamic and inclusive environment for entrepreneurship. We advance this mission in support of the GU community and for the benefit of society.

Georgetown University

Never miss an update from Georgetown University

Create your free account to connect with Georgetown University and thousands of other innovative organizations and professionals worldwide

Georgetown University

Send a request for information
to Georgetown University

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support